FindTrial
Sign In

Evaluation of serum progesterone level on the day of embryo transfer in frozen cycle at cleavage stage on pregnancy outcomes in two routes of luteal phase support in infertile women refereed to Infertility center affiliated to Hormozgan University of Medical Sciences : A randomized clinical trial study

Evaluation of serum progesterone level on the day of embryo transfer in frozen cycle at cleavage stage on pregnancy outcomes in two routes of luteal phase support in infertile women refereed to Infertility center affiliated to Hormozgan University of Medical Sciences : A randomized clinical trial study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200905048630N2
Enrollment
100
Registered
2021-08-22
Start date
2021-09-21
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility.

Interventions

Intervention 1: Intervention group 1: receiving progesterone as IM. Intervention 2: Intervention group 2: receiving vaginal progesterone( crinone gel 8%).

Sponsors

Bandare-abbas University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 37 Years

Inclusion criteria

Inclusion criteria: ICSI/FET cycles Having 2-3 high quality embryo Patients with normal uterine cavity Infertile women between 18-37 years Artificial Endometrial preparing

Exclusion criteria

Exclusion criteria: RIF patients Aged over 37 years Patients with a history of recurrent miscarriage, implantation problem Patients with uterine abnormality like Fibroma, uterine anatomical problems, Polyp, intramural Myoma greater than 4 cm, salpangitis Patients with grade 3 or 4 endometriosis Body mass index higher than 30 kg / m2 Patients using two types of progesterone to support the luteal phase Patients with blastocyst transfer (fifth day embryo) Ectopic pregnancy Patients with endometrial thickness less than 7 mm after hormone therapy Poor quality embryo

Design outcomes

Primary

MeasureTime frame
Biochemical pregnancy. Timepoint: 14 days after FET. Method of measurement: beta serum level evaluation.;Clinical pregnancy. Timepoint: 6 week after FET. Method of measurement: Sonography.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Maryam Azizi kutenaee

Bandare-abbas University of Medical Sciences

maryamazizikut86@gmail.com+98 76 3333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026